KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,329 | +68.2% | 365,024 | +95.1% | 0.16% | +82.6% |
Q2 2023 | $1,979 | +22.1% | 187,065 | +41.1% | 0.09% | +11.7% |
Q1 2023 | $1,621 | -19.3% | 132,555 | -18.1% | 0.08% | -30.6% |
Q4 2022 | $2,009 | -99.9% | 161,916 | -11.6% | 0.11% | -26.5% |
Q3 2022 | $2,501,000 | +21.7% | 183,116 | +63.3% | 0.15% | -1.9% |
Q2 2022 | $2,055,000 | +39.8% | 112,117 | +22.6% | 0.15% | +60.4% |
Q1 2022 | $1,470,000 | +181.6% | 91,437 | +145.1% | 0.10% | +47.7% |
Q4 2021 | $522,000 | -37.5% | 37,305 | -16.3% | 0.06% | -41.4% |
Q3 2021 | $835,000 | +22.8% | 44,585 | +36.8% | 0.11% | -51.5% |
Q2 2021 | $680,000 | -39.2% | 32,602 | -17.7% | 0.23% | -36.0% |
Q1 2021 | $1,119,000 | -55.4% | 39,598 | -48.4% | 0.36% | -49.9% |
Q4 2020 | $2,507,000 | +68.0% | 76,748 | +57.6% | 0.72% | +50.8% |
Q3 2020 | $1,492,000 | +24.4% | 48,689 | -33.8% | 0.47% | +16.5% |
Q2 2020 | $1,199,000 | +47.5% | 73,546 | -10.0% | 0.41% | +18.7% |
Q1 2020 | $813,000 | +104.3% | 81,717 | +182.6% | 0.34% | +188.2% |
Q4 2019 | $398,000 | – | 28,917 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |